NCT00075829 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 436
- group Id
- BG001
- value
- 189
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 710
- units
- Participants
- groups
- description
- Tandem autologous transplant plus thalidomide/dexamethasone (Thal-Dex) or observation (Obs) for standard risk patients PFS and OS did not differ between the Thal-Dex and the Obs arms and were thus pooled for analysis.
- id
- BG000
- title
- Auto-Auto Standard Risk
- description
- Autologous transplant plus non-myeloablative allogeneic transplant for standard risk patients
- id
- BG001
- title
- Auto-Allo Standard Risk
- description
- Tandem autologous transplant plus thalidomide/dexamethasone (Thal-Dex) or observation (Obs) for high risk patients PFS and OS did not differ between the Thal-Dex and the Obs arms and were thus pooled for analysis.
- id
- BG002
- title
- Auto-Auto High Risk
- description
- Autologous transplant plus non-myeloablative allogeneic transplant for high risk patients
- id
- BG003
- title
- Auto-Allo High Risk
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 70
- value
- 55
- group Id
- BG001
- lower Limit
- 29
- upper Limit
- 68
- value
- 53
- group Id
- BG002
- lower Limit
- 32
- upper Limit
- 70
- value
- 57
- group Id
- BG003
- lower Limit
- 32
- upper Limit
- 66
- value
- 51
- group Id
- BG004
- lower Limit
- 22
- upper Limit
- 68
- value
- 53.2
- dispersion Type
- INTER_QUARTILE_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 176
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 291
- title
- Female
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 111
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 21
- group Id
- BG004
- value
- 419
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 77
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 106
- title
- African American
- categories
- measurements
- group Id
- BG000
- value
- 335
- group Id
- BG001
- value
- 161
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 33
- group Id
- BG004
- value
- 567
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 37
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 344
- group Id
- BG001
- value
- 148
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 545
- title
- 100 - 90
- categories
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 165
- title
- < 90
- description
- Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.
- param Type
- NUMBER
- title
- Karnofsky Performance score
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.004
- upper Limit
- 4.0
- value
- 2.0
- group Id
- BG001
- lower Limit
- 0.9
- upper Limit
- 4.0
- value
- 2.0
- group Id
- BG002
- lower Limit
- 0.9
- upper Limit
- 9.8
- value
- 4.4
- group Id
- BG003
- lower Limit
- 1.2
- upper Limit
- 6.6
- value
- 3.7
- group Id
- BG004
- lower Limit
- 0.004
- upper Limit
- 9.8
- value
- 3.025
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- β-2 Microglobulin
- unit Of Measure
- mg/L
- classes
- categories
- measurements
- group Id
- BG000
- value
- 142
- group Id
- BG001
- value
- 59
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 220
- title
- Stages I-II
- categories
- measurements
- group Id
- BG000
- value
- 294
- group Id
- BG001
- value
- 130
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 28
- group Id
- BG004
- value
- 490
- title
- Stage III
- description
- The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.
- param Type
- NUMBER
- title
- Durie-Salmon
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 3
- upper Limit
- 55
- value
- 7
- group Id
- BG001
- lower Limit
- 4
- upper Limit
- 35
- value
- 7
- group Id
- BG002
- lower Limit
- 5
- upper Limit
- 22
- value
- 7
- group Id
- BG003
- lower Limit
- 3
- upper Limit
- 38
- value
- 7
- group Id
- BG004
- lower Limit
- 3
- upper Limit
- 55
- value
- 7
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Interval from diagnosis to transplantation
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 69
- title
- CR
- categories
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 90
- title
- Near CR
- categories
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 119
- title
- Very Good PR
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 76
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 269
- title
- PR
- categories
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 61
- title
- MR
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 37
- title
- SD
- categories
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 54
- title
- Not Evaluable
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 11
- title
- Unknown
- description
- Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)
- param Type
- NUMBER
- title
- Disease status
- unit Of Measure
- participants
- population Description
- Analysis is based on intention-to-treat data. Primary analysis of the clinical trial focused on patients meeting protocol criteria of standard risk multiple myeloma.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 436
- group Id
- BG001
- value
- 189
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 710
- units
- Participants
- groups
- description
- Tandem autologous transplant plus thalidomide/dexamethasone (Thal-Dex) or observation (Obs) for standard risk patients PFS and OS did not differ between the Thal-Dex and the Obs arms and were thus pooled for analysis.
- id
- BG000
- title
- Auto-Auto Standard Risk
- description
- Autologous transplant plus non-myeloablative allogeneic transplant for standard risk patients
- id
- BG001
- title
- Auto-Allo Standard Risk
- description
- Tandem autologous transplant plus thalidomide/dexamethasone (Thal-Dex) or observation (Obs) for high risk patients PFS and OS did not differ between the Thal-Dex and the Obs arms and were thus pooled for analysis.
- id
- BG002
- title
- Auto-Auto High Risk
- description
- Autologous transplant plus non-myeloablative allogeneic transplant for high risk patients
- id
- BG003
- title
- Auto-Allo High Risk
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 70
- value
- 55
- group Id
- BG001
- lower Limit
- 29
- upper Limit
- 68
- value
- 53
- group Id
- BG002
- lower Limit
- 32
- upper Limit
- 70
- value
- 57
- group Id
- BG003
- lower Limit
- 32
- upper Limit
- 66
- value
- 51
- group Id
- BG004
- lower Limit
- 22
- upper Limit
- 68
- value
- 53.2
- dispersion Type
- INTER_QUARTILE_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 176
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 291
- title
- Female
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 111
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 21
- group Id
- BG004
- value
- 419
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 77
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 106
- title
- African American
- categories
- measurements
- group Id
- BG000
- value
- 335
- group Id
- BG001
- value
- 161
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 33
- group Id
- BG004
- value
- 567
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 37
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 344
- group Id
- BG001
- value
- 148
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 545
- title
- 100 - 90
- categories
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 165
- title
- < 90
- description
- Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.
- param Type
- NUMBER
- title
- Karnofsky Performance score
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.004
- upper Limit
- 4.0
- value
- 2.0
- group Id
- BG001
- lower Limit
- 0.9
- upper Limit
- 4.0
- value
- 2.0
- group Id
- BG002
- lower Limit
- 0.9
- upper Limit
- 9.8
- value
- 4.4
- group Id
- BG003
- lower Limit
- 1.2
- upper Limit
- 6.6
- value
- 3.7
- group Id
- BG004
- lower Limit
- 0.004
- upper Limit
- 9.8
- value
- 3.025
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- β-2 Microglobulin
- unit Of Measure
- mg/L
- classes
- categories
- measurements
- group Id
- BG000
- value
- 142
- group Id
- BG001
- value
- 59
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 220
- title
- Stages I-II
- categories
- measurements
- group Id
- BG000
- value
- 294
- group Id
- BG001
- value
- 130
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 28
- group Id
- BG004
- value
- 490
- title
- Stage III
- description
- The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.
- param Type
- NUMBER
- title
- Durie-Salmon
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 3
- upper Limit
- 55
- value
- 7
- group Id
- BG001
- lower Limit
- 4
- upper Limit
- 35
- value
- 7
- group Id
- BG002
- lower Limit
- 5
- upper Limit
- 22
- value
- 7
- group Id
- BG003
- lower Limit
- 3
- upper Limit
- 38
- value
- 7
- group Id
- BG004
- lower Limit
- 3
- upper Limit
- 55
- value
- 7
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Interval from diagnosis to transplantation
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 69
- title
- CR
- categories
- measurements
- group Id
- BG000
- value
- 65
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 90
- title
- Near CR
- categories
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 119
- title
- Very Good PR
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 76
- group Id
- BG002
- value
- 21
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 269
- title
- PR
- categories
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 61
- title
- MR
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 37
- title
- SD
- categories
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 54
- title
- Not Evaluable
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 11
- title
- Unknown
- description
- Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)
- param Type
- NUMBER
- title
- Disease status
- unit Of Measure
- participants
- population Description
- Analysis is based on intention-to-treat data. Primary analysis of the clinical trial focused on patients meeting protocol criteria of standard risk multiple myeloma.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle